ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 788–795
DOI: 10.46882/AJIDR/149016
Article Type: Research Article
Title: Molecular epidemiology and multidrug resistance determinants of Helicobacter pylori in patients with peptic ulcer disease
Names of Authors: Ziad Al-Mansoor¹*, Clara Lindholm², Tunde Bakare³
Abstract: Helicobacter pylori chronic gastric colonization drives peptic ulceration and gastric adenocarcinoma, yet rising clarithromycin and metronidazole resistance undermines standard triple therapy. We determined cagA and vacA virulence genotypes alongside 23S ribosomal RNA and rdxA resistance mutations in gastric biopsy specimens. Antral biopsies from 240 dyspeptic adults undergoing upper endoscopy were evaluated via rapid urease testing, culture, and targeted sequencing. Clarithromycin resistance mutations at A2143G were present in 31.7 percent of isolates, while metronidazole resistance reached 64.2 percent. Bismuth-based quadruple therapy is recommended as first-line eradication treatment.
Keywords: Helicobacter pylori, Clarithromycin resistance, Peptic ulcer disease, Virulence genotypes, Antimicrobial susceptibility
Citation: Al-Mansoor Z, Lindholm C, Bakare T (2026). Molecular epidemiology and multidrug resistance determinants of Helicobacter pylori in patients with peptic ulcer disease. African Journal of Infectious Diseases Research, 13(11): 788–795. DOI: 10.46882/AJIDR/149016
Manuscript Timeline: Received: September 10, 2026; Revised: October 11, 2026; Accepted: November 06, 2026; Published: November 12, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read